ATXI
Avenue Therapeutics, Inc. Common Stock
ATXI
ATXI
Delisted
ATXI was delisted on the 18th of March, 2025.
14 hedge funds and large institutions have $503K invested in Avenue Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$45.1K | |
| 2 | +$28K | |
| 3 | +$15.4K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.17K |
| 5 |
BlackRock
New York
|
+$3.31K |
Top Sellers
| 1 | -$1.32M | |
| 2 | -$31.2K | |
| 3 | -$9K | |
| 4 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$5K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$77 |